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Abstract This study sought to monitor the presence of
carbapenem-resistant Enterobacteriaceae (CRE) and the pro-
portion NewDelhi metallo-beta-lactamase 1 (NDM-1)-produc-
ing bacteria between August 2010 and December 2012 in a
surgical hospital in Vietnam. We identified 47 CRE strains
from a total of 4,096 Enterobacteriaceae isolates (1.1 %) that
were NDM-1-positive from 45 patients admitted to 11 different
departments, with the majority being from the urology depart-
ment. The NDM-1 gene was found in seven different species.
Genotyping revealed limited clonality of NDM-1-positive iso-
lates. Most of the isolates carried the NDM-1 gene on a plasmid
and 17.8 % (8/45) of those were readily transferable. We found
five patients at admission and one patient at discharge with
NDM-1-positive bacteria in their stool. From 200 screening
environmental hospital samples, five were confirmed to be
NDM-1-positive and included Acinetobacter species (n=3)
and Enterobacter aerogenes (n=2). The results reveal that
NDM-1-producing Enterobacteriaceae are commonly isolated
in patients admitted to a Vietnamese surgical hospital and are
also detected in the hospital environment.
Introduction
Garrett Hardin’s influential 1968 essay in Science launched
the idea that common goods are under threat when individuals
use a shared resource in an unsustainable way, also known as
the Btragedy of the commons.^ [1]. The tragedy is well known
to affect global issues, from climate change to biodiversity
conservation. The shared, and originally natural, resource of
antimicrobials is another example of how a resource, antibiot-
ic effectiveness, on which we all depend can be destroyed by
using antibiotics injudiciously [2]. The problem of antibiotic
resistance has reached another climax with the discovery of
NDM-1, New Delhi metallo-beta-lactamase 1 (MBL), a gene
that confers resistance to the last-resort antibiotic class of car-
bapenems [3]. The NDM-1 gene encodes an enzyme that hy-
drolyses and inactivates carbapenems. Sequence comparisons
show that the NDM-1 gene is a chimera, formed by in-frame
fusion of a pre-existing MBL gene with the aminoglycoside
resistance gene aphA6 [4]. The resistance gene is usually lo-
cated on a plasmid that can be easily transferred to other bac-
terial strains via horizontal gene transfer. NDM-1 has already
been identified on a variety of plasmids and in a large variety
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of Gram-negative pathogens [5, 6]. In addition, sequencing
data of plasmids containing the NDM-1 gene reveal the exis-
tence of additional resistance genes [6, 7]. A bacterium carry-
ing such a plasmid is usually resistant to all antibiotics, apart
from tigecycline and colistin [6, 8].
Through increasing immigration, travel and environmental
spread, NDM-1 is reported from most continents around the
world, including more and more reports from South East Asia
[5]. In Vietnam, antibiotic resistance rates have been report-
edly high. A combination of a high infectious diseases burden,
unrestricted access to antibiotics and poor infection control
measures contribute to the emergence of antibiotic resistance
in Vietnam [9, 10].
NDM-1 has already been reported in Vietnamese pa-
tients, healthy volunteers and the environment [11–13].
However, the magnitude of the problem of carbapenem
resistance encoded by NDM-1 remains unknown. We,
therefore, carried out a surveillance project to detect
carbapenem-resistant bacteria containing the NDM-1 gene
in a large surgical hospital in Vietnam and collected key
epidemiological data.
Materials and methods
Site
This study was conducted over a period of 28 months from
August 2010 to December 2012 in a large surgical hospital in
Hanoi, Vietnam. Molecular and microbiological analyses
were performed in the hospital clinical microbiology labora-
tory and at the National Institute of Hygiene and Epidemiolo-
gy (NIHE) in Hanoi.
Study participants and sample collection
Enterobacteriaceae isolated from clinical specimens from
any hospital department were tested for antibiotic suscepti-
bility using disc diffusion testing according to international
guidelines [14]. The microbiology consultants of the hos-
pital were requested to collect and send all of bacteria
strains resistant at least to one of antibiotics in the carba-
penem group to the NIHE for further identification and
NDM-1 confirmatory testing by polymerase chain reaction
(PCR) and sequencing.
Demographic and basic clinical information were collected
from patients with carbapenem-resistant bacteria: age, gender,
date of admission, clinical department, clinical diagnosis, or-
igin of collected sample, isolated bacterial strains and date of
sample collection. Treatment and clinical outcome data were
not available for this study.
Microbiology
Bacterial species identification was performed using commer-
cial biochemical testing kits (API20E and API20NE,
bioMérieux, France). The minimum inhibitory concentrations
(MICs) for carbapenem resistance were obtained by agar di-
lution according to the Clinical and Laboratory Standards In-
stitute (CLSI) 2012 guidelines and the European Committee
on Antimicrobial Susceptibility Testing (EUCAST)
breakpoint for colistin [15].
The MBL Etest (bioMérieux, France) was used to screen
for metallo-beta-lactamase production. The NDM-1 gene of
bacterial isolates was detected by PCR using specific primers
(Kp-ndm1-F: 5′-ttcgacccagccattggcggcga-3′ and Kp-ndm1-R:
5′-atgcacccggtcgcgaagctgag-3′), as described previously [3].
We also performed PCRs to detect genes encoding
extended-spectrum beta-lactamases (ESBLs; TEM, SHV and
CTX-M). Furthermore, we checked for other genes encoding
for carbapenemases (KPC, IMP, VIM, SIM) and OXA-48, as
described elsewhere [16–21]. Positive resistant gene PCR
products were sequenced for confirmation.
Conjugational transfer of NDM-1 plasmids to the laborato-
ry strain Escherichia coli J53 was done on LB broth without
selection. After 16 h, the mixed cultured was centrifuged,
suspended in saline and plated ontoMacConkey agar contain-
ing sodium azide (100 mg/L) and meropenem (2 mg/L).
Transconjugants were confirmed to have NDM-1 by PCR
analysis. Plasmids were subsequently isolated and typed as
described by Carattoli and colleagues [22].
NDM-1-positive bacterial isolates were genotyped by
pulsed-field gel electrophoresis (PFGE), using XbaI restric-
tion enzyme (Roche Diagnostic, Mannheim, Germany) to di-
gest the bacterial genomes in agarose blocks. The resulting
DNA fragments were separated by PFGE on CHEF-DR III
apparatus (Bio-Rad, Hercules, CA, USA) for 20 h at 6 V/cm at
14 °C with an initial pulse time of 0.5 s and a final pulse time
of 30 s, as described elsewhere [23].
For the characterisation of plasmids carrying the NDM-1
gene, we treated genomic DNA in agarose blocks with restric-
tion enzyme S1 (Invitrogen, Abingdon, UK) and separated
them by PFGE. The Biometra system (Analytik Jena, Germa-
ny) was used to transfer DNA fragments from the gel to nylon
membrane and they were hybridised with NDM-1 probe la-
belled in an HL-2000 HybriLinker (UPV, Germany).
Hybridisation plasmids with NDM-1 were cut from the gel,
purified and typed as described by Carattoli and colleagues
[22].
Rectal carriage of NDM-1 at admission and discharge
We assessed the carriage rate of NDM-1-positive bacteria in
patients at admission and discharge among 103 randomly select-
ed patients admitted to the urology department, which was the
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department where most of the NDM-1-positive patients
were detected. Between May 2012 and October 2012, we
screened up to five patients per day by collecting rectal
swabs within 24 h after admission and a second rectal swab
just before discharge. We aimed to enroll 10–15 patients per
week. Rectal swabs were collected using sterile cotton-
tipped swabs (Copan, Italy) and inoculated on 5 ml of LB
broth containing imipenem (2 mg/L) for 6–8 h at 37 °C and
then plated onto selective MacConkey agar plates supple-
mented with 2 mg/L imipenem and incubated at 37 °C.
After 24–48 h, five randomly selected single colonies were
collected and tested for susceptibility to carbapenems and
the presence of the NDM-1 gene, as detailed above.
NDM-1 in the hospital environment
During the period of one week, 200 environmental samples in
the hospital were collected and tested for carbapenem-
resistant bacteria. Samples were collected from the patient’s
bed, medical and non-medical waste, floor, toilets, medical
trolley, office table, nurse’s telephone and vacuum system
for suctioning. Sterile cotton-tipped swabs (Copan, Italy) were
used to swab the surface of the collection sites and inoculated
on 5 ml of LB broth containing imipenem (2 mg/L) for 6–8 h
at 37 °C and then plated onto selectiveMacConkey agar plates
supplemented with 2 mg/L imipenem and incubated at 37 °C.
After 24–48 h, five randomly single colonies were selected
and tested for susceptibility to carbapenems and the presence
of the NDM-1 gene, as detailed above.
Statistical methods
We used the total number of collected isolates as the denom-
inator for the carbapenem resistance positivity rate calcula-
tions by SPSS, 20.0. PFGE data were analysed using
BioNumerics version 6.5 software (BioNumerics, USA).
Ethics statement
Ethical approval was obtained from the Ethical Committee of
the NIHE in 2010. Patients in the rectal carriage study provid-
ed informed consent to participate in the study.
Results
We identified 69 CRE, which included the following seven
species:Klebsiella pneumoniae (n=22), Enterobacter cloacae
(n=20),E. coli (n=15),Citrobacter freundii (n=9),K. oxytoca
(n=1), E. aerogenes (n=1) and Providencia rettgeri (n=1).
These were isolated from a total of 4,096 Enterobacteriaceae
analysed between August 2010 and December 2012. Of these
69 CRE, 47 (68.1 %) were NDM-1-positive and belonged to
seven different bacterial species: E. cloacae (n=15; 32 %),
E. coli (n=12; 26%),K. pneumoniae (n=9; 19%),C. freundii
(n=8; 17.%), P. rettgeri (n=1), E. aerogenes (n=1) and
K. oxytoca (n=1) (Fig. 1). The most common specimen
among the NDM-1-positive isolates was urine (55.5 %),
followed by tracheal aspirates (37.8 %), bronchial secretions
and blood (6.7 %). The 47 NDM-1-positive strains were iso-
lated from 45 patients. Two patients had two different bacterial
NDM-1-positive species in their urine: one patient had
C. freundii and E. cloacae and the other patient had E. cloacae
and P. rettgeri.
The median patient age was 39.5 years (range: 16 to
95 years). Among the NDM-1-positive patients, the male to
female ratio was 10.3. None of the patients had a travel history
to India or Pakistan, which are considered NDM-1 hotspots.
Twenty-six NDM-1-infected patients (53.3 %) were admitted
to the hospital for reasons related to urinary tract diseases. All
of the NDM-1-positive isolates were a cause of either a
hospital-acquired infection or colonisation. One death oc-
curred in a trauma patient (cervical fracture), which was at-
tributed to septic shock from bloodstream infection with an
NDM-1-positive isolate. All other NDM-1-positive patients
were discharged alive from the hospital.
The first NDM-1-positive pathogen was E. cloacae,
isolated from a patient in the trauma and orthopaedics
department in mid-August 2010 (Fig. 2). A few days later,
the second NDM-1-positive pathogen was detected in the
urology department. Within a month, NDM-1-positive
bacteria were detected in adjacent departments (infectious
surgery, gastrointestinal emergency and hepatobiliary de-
partments) and also in clinical departments located further
away from the urology department. At the end of 2012,
NDM-1-infected cases were found in 11 departments. The
highest number of NDM-1-positive cases was detected in
the urology department (n=24), followed by the trauma
and orthopaedic surgery (n=5), infectious surgery (n=4),
Fig. 1 Proportion of NDM-1 among phenotypic of carbapenem-resistant
bacteria
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gastrointestinal emergency (n=4), ICU (n=2) and seven
other departments. Most patients were detected in Novem-
ber 2010 (sixcases) and December 2010 (five cases;
Fig. 2). The antimicrobial susceptibilities of NDM-1-
positive isolates are listed in Table 1. One bacterium,
E. cloacae, was also resistant to colistin (>16 mg/L).
Phenotypic testing for MBL of 47 NDM-1-positive isolates
revealed that 42 isolates were positive. 5/47 isolates co-
produced OXA-48 carbapenemase, a member of the serine
beta-lactamases, whose activities are not inhibited by EDTA
and, as a result, are MBL test-negative. We detected the fol-
lowing other carbapenem resistance genes in NDM-1-
negative CRE isolates: OXA-48 (n=6, K. pneumoniae) and
KPC (n=1, E. coli). In the remaining 14 CRE isolates, no
carbapenemase genes were detected with our testing panel.
Most of these CRE also carried other resistance genes confer-
ring ESBL (Table 2).
Characterisation of NDM-1-positive bacteria
The majority of the PFGE patterns of NDM-1-positive bacte-
ria showed that these were different, suggesting limited clonal
expansion. Just three E. cloacae isolates and two E. coli iso-
lates from the urinary tract belonged to a single PFGE profile,
suggesting clonal spread.
The isolates were analysed for location of the NDM-1 gene
by Southern blotting, which showed that most NDM-1-
positive isolates carried only one type of NDM-1 plasmid.
One E. coli strain isolated in 2010 contained two different
Fig. 2 Distribution of NDM-1-
positive cases by month and
department (n=45)
Table 1 Minimum inhibitory concentrations (MICs) of NDM-1-
positive Enterobacteriaceae isolates (n=47)
Antibiotic Susceptible
(mg/L)
Intermediate
(mg/L)
Resistant
(mg/L)
Imipenem 6 (0.5–1) 13 (2) 28 (>4)
Meropenem 8 (0.5–1) 5 (2) 34 (>4)
Cefotaxime 0 0 47 (>32)
Ceftazidime 0 3 (8) 44 (>32)
Ciprofloxacin 1 (<1) 2 (2) 44 (8–256)
Amikacin 14 (<16) 7 (>16) 26 (>64)
Gentamicin 2 (0.25–1) 3 (>4) 48 (>32)
Colistin 46 (0.25–1) 0 1 (>16)
Table 2 Beta-lactamase resistance genes present on plasmids of NDM-
1-positive Enterobacteriaceae isolates (n=47)
Species TEM SHV CTX-M
Enterobacter cloacae (n=15) 15 4 6
Klebsiella pneumoniae (n=9) 8 ND 6
Escherichia coli (n=12) 11 3 7
Citrobacter freundii (n=8) 8 – 3
Providencia rettgeri (n=1) 1 – 1
Enterobacter aerogenes (n=1) – – 1
Klebsiella oxytoca (n=1) 1 – 1
Total 44 12 25
ND not done, as SHV was expected to be present on the chromosome of
most Klebsiella species
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plasmids with the NDM-1 gene (Fig. 3). The size of the NDM-
1 isolate containing plasmids ranged from 50 to 150 kb and
were characterised as follows: incompatibility type FIIs-repA
(n=16), N-repA (n=3) and IncA/C (n=4). The remaining iso-
lates could not be typed (Table 3). We found two isolates,
E. coli and E. cloacae, that carried the NDM-1 gene on their
chromosomes. Transconjugants were performed for 45 clini-
cal isolates. 17.8 % (8/45) of isolates transferred their NDM-1
plasmid to E. coli J53. All of transconjugants were confirmed
to be NDM-1-positive.
NDM-1 rectal carriage and presence in the environment
We screened the stool specimens of 103 patients at admission
and discharge. We found five patients with NDM-1-positive
bacteria at admission: E. coli, K. pneumoniae, E. cloacae,
P. mirabilis and Acinetobacter spp. at admission. Two of the
patients—both hepatobiliary surgery—were NDM-1-negative
at discharge, one after spending 21 days in the hospital and the
other after spending 3 days in the hospital. One patient was
negative at admission and positive with P. mirabilis carrying
the NDM-1 gene at discharge.
Screening environmental hospital samples (n=200) for
CRE showed the following: 138 were negative, 62 were pos-
itive of which, 31 were Acinetobacter species, seven
Enterobacter species, eight Klebsiella species, three E. coli,
12 Pseudomonas species and a single case of Citrobacter
species. From the 62 positive screen samples, only five were
confirmed to be NDM-1-positive. Three of the five NDM-1-
positive strains were Acinetobacter species that were isolated
from the patients’ beds. The other two positive cases were
E. aerogenes, isolated from a toilet seat and a medical waste
bin. We could only classify one plasmid of the E. aerogenes
isolate that was found on the toilet seat in the urology depart-
ment. It was an N-repA plasmid, which was also found in
clinical Acinetobacter isolates.
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bromide. The molecular weight
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Table 3 Plasmid replicon types of NDM-1-positive isolates
Species Plasmid replicon type
FIIs-repA IncA/C Untypeable
Enterobacter cloacae (n=14) 7 1 6
Klebsiella pneumoniae (n=9) 3 2 4
Escherichia coli (n=11) 4 – 7
Citrobacter freundii (n=8) 1 1 6
Providencia rettgeri (n=1) – – 1
Enterobacter aerogenes (n=1) – – 1
Klebsiella oxytoca (n=1) 1 – –
Total (n=45) 16 4 25
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Discussion
The present study demonstrates that carbapenem resistance
among Enterobacteriaceae due to NDM-1 is frequently isolat-
ed in a major surgical hospital in Vietnam. NDM-1 constituted
1.1 % of all Enterobacteriaceae in our study and 68.1 % of
CRE. This is comparable to the 1.2 % NDM-1 prevalence
amongst Enterobacteriaceae reported by Kumarasamy and
colleagues in India in 2010 [23].Wemay have underestimated
the number of CRE as we used a relatively high concentration
of imipenem in our screening broth. In the United States, only
seven NDM-1-producing CRE have been reported to the Cen-
ters for Disease Control and Prevention (CDC) from clinical
isolates between 2009 and 2011, with most patients having
links to travel to Asia [24]. Having found 68.1% of all CRE to
be NDM-1-positive is alarming. Furthermore, we found CRE
containing OXA-48 and KPC. Still, a number of CRE isolates
were negative for all the tested genes, and are currently being
characterised further using sequencing techniques.
The most common bacterial species carrying NDM-1 were
E. cloacae, E. coli, K. pneumoniae and C. freundii. All of them
belong to the human gut flora and are widespread in the envi-
ronment. NDM-1 has been detected in a river in Hanoi, illus-
trating the environmental spread of NDM-1 in Hanoi [12]. We
found five patients who carried NDM-1 rectally at admission,
demonstrating the scope of NDM-1 spread among admitted
patients from the community and also the transmission of
NDM-1 between different hospitals; three of the five positive
patients at admission had been transferred from another hospi-
tal. An investigation of NDM-1 resistance in the other hospitals
would help to better understand the resistance spread. Further-
more, in one household member of an NDM-1-positive patient,
we found an NDM-1-positive Proteus mirabilis, again illustrat-
ing the potential spread in the community. In a recent cross-
sectional community-based study, NDM-1-positive
K. pneumoniae were cultured from the nasopharynx in two
healthy volunteers in Hanoi [13]. Our examination of the hos-
pital’s environment for NDM-1 contamination revealed three
NDM-1-positive Acinetobacter isolates and only 6/436
carbapenem-resistant Acinetobacter isolates were NDM-1-pos-
itive. Possibly, Acinetobacter species play a role as an environ-
mental NDM-1 reservoir that can function as a conduit of
NDM-1 containing plasmids to other bacterial genera, such as
K. pneumoniae [25, 26]. Replicate typing revealed that clinical
isolates and environmental isolates contain similar plasmid
types. However, plasmid genome sequencing could provide
better insight into this, which was not performed.
The majority of positive cases originated from the urology
department. Since the faecal flora can serve as an antibiotic
resistance reservoir for uropathogens and due to the fact that
most patients were catheterised may explain this finding [27].
Also, these patients may have been cultured more frequently,
leading to selection bias. NDM-1-positive bacteria were
detected sooner in departments adjacent to the urology depart-
ment as compared to more distant departments. These observa-
tions suggest that the urology department is a potential NDM-1
hotspot from where NDM-1-positive bacteria disseminated to
different departments in the hospital, either by transferred pa-
tients or by healthcare workers. In an outbreak of carbapenem-
resistant K. pneumoniae with 18 patients, they identified three
independent transmissions from a single patient that had been
discharged before the second case was detected.
In our study, PFGE showed genetic diversity amongNDM-1
and, thus, there is limited evidence of clonal expansion,
confirming that horizontal gene transfer of NDM-1 containing
plasmids is the main mechanism of spread. Besides the large
variety in NDM-1-positive species, the NDM-1 gene was also
carried by various plasmid types: IncA/C, IncF, IncN or
untypeable, similar to other studies [28]. In the literature, the
NDM-1 gene has been more frequently reported on broad host
range IncA/C-type plasmids [29]. In Vietnam, most plasmids
were IncFII, which has been found in Poland as well, and was
recently sequenced [29–31]. The observation that the majority
of NDM-1 was found on IncFII plasmids is alerting, as this
plasmid type can spread efficiently, as was seen with the world-
wide dissemination of blaCTX-—15-borne IncFII plasmids [29].
IncFII-type plasmids are considered narrow host range plasmids
usually identified among E. coli strains [32]. However, in our
study, IncFII were also detected in E. cloacae, K. pneumoniae
and C. freundii. As these plasmids are characterised by several
toxin–antitoxin addiction systems, they are efficiently passed on
during bacterial cell division. The Acinetobacter isolates appear
to have generally N-repA plasmids, which were not observed in
Enterobacteriaceae (data not shown).
We were unable to assess the clinical significance of NDM-
1 regarding antibiotic treatment and outcome, which is a limi-
tation of our study. In a previous report from two patients in the
same hospital, there was no evidence of poor clinical outcome
and the NDM-1-positive bacteria were likely colonisers rather
than pathogens. However, as the plasmids can be easily trans-
ferred, the potential of NDM-1 spreading to disease-causing
bacteria is a serious threat and can result in high morbidity
and mortality, as was seen in the UK [21]. Future studies would
need to incorporate clinical data in order to obtain the full
picture. Unfortunately, we did not have access to these data.
Conclusion
With the present study, we have gained insight into the spread
of an important antibiotic-resistant gene in a major hospital in
Hanoi, Vietnam. We also documented patients admitted and
discharged while being colonised with New Delhi metallo-
beta-lactamase 1 (NDM-1)-positive bacteria and even demon-
strated a household to be contaminated with NDM-1-positive
bacteria. Furthermore, NDM-1 was found in environmental
1252 Eur J Clin Microbiol Infect Dis (2015) 34:1247–1254
bacteria. This indicates that NDM-1 has infiltrated both the
healthcare as well as the community settings. The issue of
carbapenem resistance needs both hospital- and community-
based control efforts.
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